- Home
- GENC vs CADL Comparison
GENC vs CADL Comparison
Compare GENC & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- CADL
- Stock Information
- Founded
- GENC 1894
- CADL 1999
- Country
- GENC United States
- CADL United States
- Employees
- GENC N/A
- CADL N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- GENC Industrials
- CADL Health Care
- Exchange
- GENC Nasdaq
- CADL Nasdaq
- Market Cap
- GENC 211.1M
- CADL 234.8M
- IPO Year
- GENC N/A
- CADL 2021
- Fundamental
- Price
- GENC $14.12
- CADL $4.81
- Analyst Decision
- GENC
- CADL Strong Buy
- Analyst Count
- GENC 0
- CADL 4
- Target Price
- GENC N/A
- CADL $21.00
- AVG Volume (30 Days)
- GENC 18.7K
- CADL 900.5K
- Earning Date
- GENC 08-08-2025
- CADL 08-12-2025
- Dividend Yield
- GENC N/A
- CADL N/A
- EPS Growth
- GENC 35.02
- CADL N/A
- EPS
- GENC 1.11
- CADL N/A
- Revenue
- GENC $113,116,000.00
- CADL N/A
- Revenue This Year
- GENC N/A
- CADL N/A
- Revenue Next Year
- GENC N/A
- CADL N/A
- P/E Ratio
- GENC $12.73
- CADL N/A
- Revenue Growth
- GENC 5.44
- CADL N/A
- 52 Week Low
- GENC $10.80
- CADL $3.79
- 52 Week High
- GENC $24.88
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- GENC 52.65
- CADL 39.51
- Support Level
- GENC $13.81
- CADL $4.84
- Resistance Level
- GENC $14.77
- CADL $6.20
- Average True Range (ATR)
- GENC 0.48
- CADL 0.36
- MACD
- GENC -0.04
- CADL -0.10
- Stochastic Oscillator
- GENC 54.48
- CADL 5.09
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.